AC Immune SA
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
ACIU | US
Overview
Corporate Details
- ISIN(s):
- CH0329023102
- LEI:
- Country:
- United States of America
- Address:
- EPFL INNOVATION PARK, BUILDING B, 0 1015 LAUSANNE
- Website:
- https://www.acimmune.com/
- Sector:
- Manufacturing
Description
AC Immune SA is a clinical-stage biopharmaceutical company specializing in precision medicine for neurodegenerative diseases. The company pioneers novel approaches to diagnose, treat, and prevent conditions driven by misfolded proteins, including Alzheimer's disease, Parkinson's disease, and other rare indications. Its diversified pipeline includes therapeutic and diagnostic candidates developed through proprietary technology platforms. These candidates encompass various treatment modalities such as active immunotherapies, antibodies, and small molecules. The company's scientific and clinical strategies are validated through collaboration partnerships with global pharmaceutical leaders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AC Immune SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AC Immune SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AC Immune SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
